Svenningsson A - Search Results

1

Rituximab in paediatric onset multiple sclerosis: a case series.

Salzer J, Lycke J, Wickström R, Naver H, Piehl F, Svenningsson A. Salzer J, et al. Among authors: svenningsson a. J Neurol. 2016 Feb;263(2):322-326. doi: 10.1007/s00415-015-7979-x. Epub 2015 Nov 24. J Neurol. 2016. PMID: 26603152

2

No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis.

Svenningsson A, Lycke J, Svennerholm B, Gronowitz S, Andersen O. Svenningsson A, et al. Ann Neurol. 1992 Nov;32(5):711-4. doi: 10.1002/ana.410320518. Ann Neurol. 1992. PMID: 1333176

3

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

Svenningsson A, Runmarker B, Lycke J, Andersen O. Svenningsson A, et al. Acta Neurol Scand. 1990 Sep;82(3):161-8. doi: 10.1111/j.1600-0404.1990.tb04483.x. Acta Neurol Scand. 1990. PMID: 2270743

4

Human spumaretrovirus antibody reactivity in multiple sclerosis.

Lycke J, Svennerholm B, Svenningsson A, Muranyi W, Flügel RM, Andersen O. Lycke J, et al. Among authors: svenningsson a. J Neurol. 1994 Feb;241(4):204-9. doi: 10.1007/BF00863769. J Neurol. 1994. PMID: 8195818

5

Possible association of HTLV-I infection and dementia.

Lycke J, Svennerholm B, Svenningsson A, Horal P, Nordqvist-Brandt E, Andersen O. Lycke J, et al. Among authors: svenningsson a. Acta Neurol Scand. 1993 Sep;88(3):199-203. doi: 10.1111/j.1600-0404.1993.tb04216.x. Acta Neurol Scand. 1993. PMID: 8256556

6

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

Svenningsson A, Hansson GK, Andersen O, Andersson R, Patarroyo M, Stemme S. Svenningsson A, et al. Ann Neurol. 1993 Aug;34(2):155-61. doi: 10.1002/ana.410340210. Ann Neurol. 1993. PMID: 8338339

7

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis.

Andersen O, Lycke J, Tollesson PO, Svenningsson A, Runmarker B, Linde AS, Aström M, Gjörstrup P, Ekholm S. Andersen O, et al. Among authors: svenningsson a. Neurology. 1996 Oct;47(4):895-900. doi: 10.1212/wnl.47.4.895. Neurology. 1996. PMID: 8857715 Clinical Trial.

8

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis.

Andersen O, Lycke J, Tollesson PO, Svenningsson A, Runmarker B, Linde AS, Aström M, Gjörstrup P, Ekholm S. Andersen O, et al. Among authors: svenningsson a. Mult Scler. 1996 Jul;1(6):348. doi: 10.1177/135245859600100613. Mult Scler. 1996. PMID: 9345415 Clinical Trial. No abstract available.

9

Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.

Svenningsson A, Petersson AS, Andersen O, Hansson GK. Svenningsson A, et al. Neurology. 1999 Nov 10;53(8):1880-2. doi: 10.1212/wnl.53.8.1880. Neurology. 1999. PMID: 10563648

10

Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.

Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Lindå H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Hammarberg H, et al. Among authors: svenningsson a. J Neurosci. 2000 Jul 15;20(14):5283-91. doi: 10.1523/JNEUROSCI.20-14-05283.2000. J Neurosci. 2000. PMID: 10884312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters